Company Filing History:
Years Active: 2002
Title: Innovator Mark Edward Curran: Trailblazer in Potassium Channel Research
Introduction: Mark Edward Curran is a notable inventor based in Raleigh, NC, with a focus on innovative approaches to understanding human potassium channels. His work contributes significantly to the fields of genetics and physiology, underlining the importance of nucleic acid research in medical applications.
Latest Patents: Curran holds one patent titled "Nucleic acid encoding human potassium channel K⁺ nov1 protein." This patent provides methods for isolating K⁺Hnov genes and highlights the utility of K⁺Hnov nucleic acid compositions in identifying homologous or related proteins. The inventions have vast applications, including producing compositions that can modulate the expression or function of the potassium channel protein and studying related physiological pathways. Moreover, the modulation of gene activity in vivo has potential applications in prophylactic and therapeutic contexts, such as identifying specific cell types based on gene expression.
Career Highlights: Curran is associated with Icagen, Inc., a company that focuses on pioneering drug discovery and development, particularly in the realm of ion channels and neurological disorders. His contributions to the field of potassium channels are indicative of his expertise and drive for advancement in biotechnology.
Collaborations: Throughout his career, Curran has worked with esteemed colleagues, including Andrew Miller and Ping Hu. Collaborating with such talented professionals has allowed him to expand his innovations and enhance research outcomes in their shared scientific pursuits.
Conclusion: Mark Edward Curran's innovative work in the field of potassium channel research exemplifies the impact of dedicated inventors in science and medicine. His patent reflects significant advancements that have potential implications for therapeutic interventions and greater understanding of physiological processes, marking him as a vital contributor to modern biotechnological advances.